Commentary
Commentary
Medicare For All Would Wipe Out Jobs, Pensions, and 401(k)s
Donald Trump famously made “You’re fired!” a household catchphrase. It may re-enter the American vernacular if the likes of Senators Bernie Sanders, Elizabeth Warren, or Kamala Harris take the White House. That’s because Sanders, Warren, and Harris — along with Kirsten Gillibrand and Cory Booker, who are also competing for ...
Sally C. Pipes
July 3, 2019
Commentary
Three Democratic deceptions on health care during the debates
Health care dominated the two Democratic presidential debates last week. Among the most dramatic moments was when moderator Lester Holt asked the candidates to raise their hands if they supported outlawing private insurance and forcing everyone onto a new government-run, “Medicare-for-all” plan. During each debate, only two candidates — Sen. Elizabeth Warren and Mayor Bill ...
Sally C. Pipes
July 1, 2019
Commentary
PRI All Stars on 1st Democratic Presidential Debate
The PRI All Stars share their thoughts on the 1st Democratic presidential debate and analyze of the policy platforms put forward by the 20 candidates. Who won? Who lost? Did anyone have a major gaffe? Did anyone really help themselves on their quest to win the White House? Who presented ...
Pacific Research Institute
July 1, 2019
Commentary
How much does your health care cost? Trump wants you to know and save money
President Trump recently signed an executive order that aims to force hospitals, doctors, and insurers to be more transparent about their prices. Currently, those prices are negotiated and set in secret. Consumers have no idea what their care will cost and so are unable to shop around for the best ...
Sally C. Pipes
June 29, 2019
Commentary
Cost-Saving Biosimilars’ Many Obstacles
Innovating new drugs is an expensive and uncertain business, typically taking 10-12 years and costing, on average, $2.55 billion to bring a new product to market. The risks are enormous, and deserve significant financial rewards; at the same time, it’s undeniable that the costs of many new, complex drugs are ...
Henry Miller, M.S., M.D.
June 28, 2019
Commentary
Flawed WHO Study Could Jeopardize Patients’ Access to Cancer Medicines
Determining whether the prices for medicines are appropriate or not is critically important, which is why studies that attempt to answer this question must stand up to scrutiny. Studies that undervalue medicines jeopardize the development of future cures, while studies that overvalue medicines justify the imposition of excessive health care ...
Wayne Winegarden
June 27, 2019
Business & Economics
Loan rate-cap bill would harm consumers
The California Senate Banking Committee is scheduled to hold a hearing Wednesday (June 26) on a bill that caps consumer loan rates and threatens to sever a vital credit lifeline for many. Oddly, three commercial lenders who offer the kind of loans subject to this regulation support it. Assembly Bill ...
Kerry Jackson
June 25, 2019
Charter Schools
Charter Schools Don’t Fiscally Distress Regular Public Schools
In their continuing war against charter schools, teacher unions have persistently argued that charter schools, which are mostly non-union, have a large negative financial impact on the regular public school system. New research, however, contradicts this claim. In Sacramento, the California Teachers Association is pushing a package of anti-charter-school bills, ...
Lance Izumi
June 24, 2019
Commentary
‘Medicare for All’ Is A Trap for Businesses and Employees
Some business leaders are hopping aboard the Medicare for All bandwagon. The Business Alliance for a Healthy California, for example, now has 300 businesses calling for universal healthcare. But any businessman considering getting behind Medicare for All should know the sales pitch is flawed. The architects of Medicare for All ...
Sally C. Pipes
June 24, 2019
Commentary
Democrats don’t understand ‘Medicare-for-all’
Next week, 20 Democratic presidential hopefuls will gather in Miami for their first debate. One issue is sure to dominate the discussion – “Medicare-for-all.” The promise of free, government-run health care has become quite popular among Democrats since Sen. Bernie Sanders, I-Vt., made it a major plank of his 2016 ...
Sally C. Pipes
June 22, 2019
Medicare For All Would Wipe Out Jobs, Pensions, and 401(k)s
Donald Trump famously made “You’re fired!” a household catchphrase. It may re-enter the American vernacular if the likes of Senators Bernie Sanders, Elizabeth Warren, or Kamala Harris take the White House. That’s because Sanders, Warren, and Harris — along with Kirsten Gillibrand and Cory Booker, who are also competing for ...
Three Democratic deceptions on health care during the debates
Health care dominated the two Democratic presidential debates last week. Among the most dramatic moments was when moderator Lester Holt asked the candidates to raise their hands if they supported outlawing private insurance and forcing everyone onto a new government-run, “Medicare-for-all” plan. During each debate, only two candidates — Sen. Elizabeth Warren and Mayor Bill ...
PRI All Stars on 1st Democratic Presidential Debate
The PRI All Stars share their thoughts on the 1st Democratic presidential debate and analyze of the policy platforms put forward by the 20 candidates. Who won? Who lost? Did anyone have a major gaffe? Did anyone really help themselves on their quest to win the White House? Who presented ...
How much does your health care cost? Trump wants you to know and save money
President Trump recently signed an executive order that aims to force hospitals, doctors, and insurers to be more transparent about their prices. Currently, those prices are negotiated and set in secret. Consumers have no idea what their care will cost and so are unable to shop around for the best ...
Cost-Saving Biosimilars’ Many Obstacles
Innovating new drugs is an expensive and uncertain business, typically taking 10-12 years and costing, on average, $2.55 billion to bring a new product to market. The risks are enormous, and deserve significant financial rewards; at the same time, it’s undeniable that the costs of many new, complex drugs are ...
Flawed WHO Study Could Jeopardize Patients’ Access to Cancer Medicines
Determining whether the prices for medicines are appropriate or not is critically important, which is why studies that attempt to answer this question must stand up to scrutiny. Studies that undervalue medicines jeopardize the development of future cures, while studies that overvalue medicines justify the imposition of excessive health care ...
Loan rate-cap bill would harm consumers
The California Senate Banking Committee is scheduled to hold a hearing Wednesday (June 26) on a bill that caps consumer loan rates and threatens to sever a vital credit lifeline for many. Oddly, three commercial lenders who offer the kind of loans subject to this regulation support it. Assembly Bill ...
Charter Schools Don’t Fiscally Distress Regular Public Schools
In their continuing war against charter schools, teacher unions have persistently argued that charter schools, which are mostly non-union, have a large negative financial impact on the regular public school system. New research, however, contradicts this claim. In Sacramento, the California Teachers Association is pushing a package of anti-charter-school bills, ...
‘Medicare for All’ Is A Trap for Businesses and Employees
Some business leaders are hopping aboard the Medicare for All bandwagon. The Business Alliance for a Healthy California, for example, now has 300 businesses calling for universal healthcare. But any businessman considering getting behind Medicare for All should know the sales pitch is flawed. The architects of Medicare for All ...
Democrats don’t understand ‘Medicare-for-all’
Next week, 20 Democratic presidential hopefuls will gather in Miami for their first debate. One issue is sure to dominate the discussion – “Medicare-for-all.” The promise of free, government-run health care has become quite popular among Democrats since Sen. Bernie Sanders, I-Vt., made it a major plank of his 2016 ...